Ocular Infections and Treatments
Ocular Infections and Treatments is a research topic within Ophthalmology. Science Explorer counts 20k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, risk factors, microbiological spectrum, antibiotic resistance, and management strategies for ocular infections such as endophthalmitis, keratitis, and fungal keratitis. It also explores the impact of cataract surgery and intravitreal injections on the development of these infections, as well as the composition of conjunctival flora.
- Endophthalmitis
- Keratitis
- Ocular Infections
- Antibiotic Resistance
- Fungal Keratitis
- Cataract Surgery
- Microbial Spectrum
- Intravitreal Injection
- Conjunctival Flora
- Corneal Blindness
- Research works
- 20k fractional, since 1950
- In the world top 10%
- 2k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +5% the tick is no change
- Largest producer
United States
28% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Ocular Infections and Treatments research?
By volume, the United States and India publish the most (798 and 603 works in 2022-now).
By volume, 2022-now
- 1
United States 798 works
- 2
India 603 works
- 3
China 487 works
- 4
United Kingdom 204 works
- 5
Spain 137 works
- 6
Germany 137 works
- 7
Japan 125 works
- 8
Türkiye 120 works
- 9
Italy 118 works
- 10
South Korea 102 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Ocular Infections and Treatments research?
By volume in 2022-now, L V Prasad Eye Institute publishes the most Ocular Infections and Treatments research, followed by All India Institute of Medical Sciences and Aravind Eye Hospital.
By volume, 2022-now
- 1
L V Prasad Eye Institute
India 76 works
- 2
All India Institute of Medical Sciences
India 55 works
- 3
Aravind Eye Hospital
India 42 works
- 4
Harvard University
United States 33 works
- 5
Creative Commons
United States 30 works
- 6
University College London
United Kingdom 29 works
- 7
University of Miami
United States 28 works
- 8
Capital Medical University
China 26 works
- 9
Sankara Nethralaya
India 25 works
- 10
Johns Hopkins University
United States 23 works
Who are the leading researchers in Ocular Infections and Treatments?
The most-cited researchers publishing on Ocular Infections and Treatments include Jost Bruno Jonas, Gordon Henry Guyatt and Rakhi Dandona.
- 1
Jost Bruno Jonas
Germany 350k citations
- 2
Gordon Henry Guyatt
Canada 315k citations
- 3
Rakhi Dandona
United States 280k citations
- 4
Yousef Saleh Khader
Jordan 274k citations
- 5
Hagop M. Kantarjian
United States 273k citations
- 6
Cornelia M. van Duijn
Netherlands 250k citations
- 7
Tien Yin Wong
Singapore 237k citations
- 8
Kai You Wang
China 224k citations
- 9
Tianjing Li
United States 219k citations
- 10
Aziz Sheikh
United Kingdom 214k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Ocular Infections and Treatments research done?
The largest centres of Ocular Infections and Treatments research in 2022-now are Hyderabad (India), London (United Kingdom), Beijing (China) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Madurai, Mountain View and Coral Gables.
Largest cities, 2022-now
Where it is the local speciality
- MaduraiIN · 43.8 works38×
- Mountain ViewUS · 29.6 works13×
- Coral GablesUS · 24.1 works12×
- HyderabadIN · 86.9 works11×
Location quotient: how much more of its research is in Ocular Infections and Treatments than the world average.
Where is the best place to study Ocular Infections and Treatments?
Among universities, judged by research, Qingdao University, Johns Hopkins University and Wenzhou Medical University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Ocular Infections and Treatments, country by countryIs Ocular Infections and Treatments research growing?
Output in 2022-2025 was 5% higher than in 2018-2021, peaking in 2026. The fastest-growing topics are Ocular Infections and Treatments.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Ocular Infections and Treatments as a percentage of every work published that year, 0.015% in 2024.
Fractional works of Ocular Infections and Treatments over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Ocular Infections and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.